Showing results (271-280 of 279) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 279 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trialM Stahl, H Wilke, U Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
Medical Physics|November 4, 2025
A dynamic anthropomorphic phantom for end-to-end testing in image- and surface-guided adaptive radiotherapyAnahita Bakhtiari Moghaddam, A Runz, R Figueiredo Augusto, et al.
Mucosal Immunology|December 20, 2012
TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammationS Jin, J Chin, S Seeber, et al.
Breast Cancer Research and Treatment|September 3, 1999
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study GroupO Kloke, U Klaassen, C Oberhoff, et al.
Seminars in Oncology|June 1, 1996
Epirubicin and ifosfamide in metastatic breast cancerR Becher, O Kloke, J Hayungs, et al.
Gene Therapy|December 1, 1996
Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAPG McLachlan, L P Ho, H Davidson-Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 28